HIGHLIGHTS
- who: Lingling Wang and colleagues from the of Brescia, Italy have published the Article: Case report: Zanubrutinib-induced dermatological toxicities: A single-center experience and review, in the Journal: (JOURNAL)
- what: Account this patient`s zanubrutinib-related dermatological toxicity for the following reasons. The authors report the first three cases of dermatological toxicities due to zanubrutinib. This is the purpose of the study as a way to draw the attention of investigators and to Incidence of zanubrutinib-associated dermatological toxicities
SUMMARY
BTK is a non-receptor tyrosine kinase in the Tec . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.